Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset
Pharmacology Biochemistry and Behavior · 2026-10 · 267 · 174247
DOI: 10.1016/j.pbb.2026.174247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026-10. Verfasst von Imane Frouni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada. Hauptthemen laut MEDLINE: Receptors, Metabotropic Glutamate, Levodopa, Dyskinesia, Drug-Induced, Antiparkinson Agents. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Parkinson Canada.
Abstract (Originalsprache)
The treatment of advanced Parkinson's disease (PD) remains challenging, with few options to address motor fluctuations and dyskinesia simultaneously. Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors may be a therapeutic option that could alleviate both fluctuations and dyskinesia. mGlu4 receptors form hetero-dimers with metabotropic glutamate 2 (mGlu2) receptors, suggesting that additive anti-parkinsonian and antidyskinetic could be obtained upon dual mGlu2-mGlu4 positive allosteric modulation. Here, the mGlu2 positive allosteric modulator (PAM) LY-487,379 and the mGlu4 PAM ADX-88178 were administered, either alone or together, in combination with L-3,4-dihydroxyphenylalanine (L-DOPA), to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmosets, after which the severity of parkinsonism, dyskinesia and psychosis-like behaviours (PLBs) was assessed. We discovered that each of LY-487,379 and ADX-88178 enhanced the anti-parkinsonian action of L-DOPA and reduced dyskinesia severity when administered separately; when administered concurrently, the resulting anti-parkinsonian (P < 0.001) and anti-dyskinetic (P < 0.01) effects were greater than when both molecules were administered separately. LY-487,379, but not ADX-88178, alleviated L-DOPA-induced PLBs; when the two compounds were administered simultaneously, the resulting anti-psychotic benefit was greater than the effect achieved with LY-487,379 (P < 0.01). Our results indicate that dual mGlu2-mGlu4 positive allosteric modulation results in greater anti-parkinsonian and anti-dyskinetic effects than positive allosteric modulation of either target separately. In addition dual mGlu2-mGlu4 positive allosteric modulation enhances the anti-psychotic effect of selective mGlu2 positive allosteric modulation. Concurrent mGlu2-mGlu4 positive allosteric modulation represents a promising avenue for the treatment of complications in advanced PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada.
- Comparative Medicine and Animal Resource Centre, McGill University, Montreal, QC, Canada.
- Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; Division of Neurology, Department of Neurosciences, McGill U…
Förderung
- Parkinson Canada
Zitieren
APA
Frouni, I., Kwan, C., Belliveau, S., Kang, W., Hamadjida, A., Gourdon, J. C., Nuara, S. G., Bédard, D., & Huot, P. (2026). Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset. Pharmacology Biochemistry and Behavior, 267, 174247. https://doi.org/10.1016/j.pbb.2026.174247
Vancouver
Frouni I, Kwan C, Belliveau S, Kang W, Hamadjida A, Gourdon JC, et al. Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset. Pharmacology Biochemistry and Behavior. 2026;267:174247. doi:10.1016/j.pbb.2026.174247
BibTeX
@article{Frouni2026,
author = {Frouni, Imane and Kwan, Cynthia and Belliveau, Sébastien and Kang, Woojin and Hamadjida, Adjia and Gourdon, Jim C and Nuara, Stephen G and Bédard, Dominique and Huot, Philippe},
title = {Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset},
journal = {Pharmacology Biochemistry and Behavior},
year = {2026},
volume = {267},
pages = {174247},
doi = {10.1016/j.pbb.2026.174247}
}
EUVIMED